Skip to main content

Clinical Trials Using Leuprolide Acetate

Review the clinical trials studying leuprolide acetate on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-7 of 7

Comparing the Outcome of Standard Systemic Therapy Only versus Standard Systemic Therapy with Either Surgery or Radiation Therapy, for Patients with Advanced Prostate Cancer
Status: Active
Location: 326 locations
Treating Prostate Cancer That Has Come Back after Surgery with Apalutamide and Targeted Radiation Based on PET Imaging, INDICATE Trial
Status: Active
Location: 303 locations
Combination of Avutometinib, Defactinib, and Letrozole for the Treatment of Low-Grade Serous Ovarian Cancer
Status: Active
Location: 8 locations
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Active
Location: 5 locations
Neoadjuvant Leuprolide Acetate and Darolutamide with Pembrolizumab, Followed by Adjuvant Pembrolizumab for the Treatment of Intermediate or High-Risk Localized and Locally Advanced Prostate Adenocarcinoma
Status: Active
Location: Icahn School of Medicine at Mount Sinai, New York, New York
Testosterone and ZEN-3694 followed by Enzalutamide and ZEN-3694 for the Treatment of Asymptomatic Patients with Metastatic Castration-Resistant Prostate Cancer, The COSMYC Trial
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients with Metastatic Castration Resistant Prostate Cancer
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York